The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA).
Karen A. Beaty
No relevant relationships to disclose
Joshua S. Hill
No relevant relationships to disclose
Safia Rafeeq
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Tara L. Sagebiel
No relevant relationships to disclose
Aurelio Matamoros
No relevant relationships to disclose
Richard E. Royal
No relevant relationships to disclose
Paul F. Mansfield
No relevant relationships to disclose
Keith F. Fournier
No relevant relationships to disclose